Advertisement

The Natural History and Management of Alcoholic Liver Disease

  • Kurt J. Isselbacher
  • Edward R. Feller

Abstract

It is evident from the title of this presentation that it is one which could be the topic of an entire symposium rather than the subject of a brief dissertation. Thus, of necessity, this presentation will be a limited review of a series of selected components of this very complex problem.

Keywords

Esophageal Varix Alcoholic Liver Disease Alcoholic Hepatitis Alcoholic Cirrhosis Portacaval Shunt 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Viewpoints on Digestive Diseases, Vol 1, No 1, April, 1969Google Scholar
  2. 2.
    POWELL WJ, KLATSKIN G: Duration of survival in patients with Laennec’s cirrhosis. Am J Med 44; 406–420, 1968PubMedCrossRefGoogle Scholar
  3. 3.
    BRUNT PW, KEW MC, SCHEUER PJ, SHERLOCK S: Studies in alcoholic liver disease in Britain. I. Clinical and pathologic patterns related to natural history. Gut 15: 52–58, 1974PubMedCrossRefGoogle Scholar
  4. 4.
    SOTERAKIS J, RESNICK RH, IBER F: Effect of alcohol abstinence on survival in cirrhotic portal hypertension. Lancet 2: 65–67, 1973CrossRefGoogle Scholar
  5. 5.
    LEEVY CM, CHEM T, ZETTERMAN RK: Alcoholic hepatitis, cirrhosis. and immunologic reactivity. Ann NY Acad Sci 252; 106–115, 1975CrossRefGoogle Scholar
  6. 6.
    PALMER ED, JAHNKE EJ, HUGHES CS: Evaluation of clinical results of portal decompression in cirrhosis. JAMA 164; 746–748, 1957CrossRefGoogle Scholar
  7. 7.
    JACKSON FC, PERRIN EB, SMITH AG, DAGRADI AE, NADAL HM: A clinical investigation of the portacaval shunt. II. Survival analysis of the prophylactic operation. Am J Surg 115: 22–42, 1968PubMedCrossRefGoogle Scholar
  8. 8.
    RESNICK RH, CHALMERS TC, ISHIHARA AM, GARCEAU AJ, CALLOW AD, SCHIMMEL EM, O’HARA ET: A controlled study of the prophylactic portacaval shunt. A final report. Ann Int Med 70: 675–688, 1969PubMedGoogle Scholar
  9. 9.
    CONN HO, LINDERMUTH WW, MAY CJ, RAMSBY GR: Prophylactic portacaval anastomosis. A tale of two studies. Medicine 51: 27–40, 1972PubMedCrossRefGoogle Scholar
  10. 10.
    JACKSON FC, PERRIN ED, FELIX R, SMITH AG: A clinical investigation of the portacaval shunt. V. Survival analysis of the therapeutic operation. Ann Surg 174: 672–701, 1971PubMedCrossRefGoogle Scholar
  11. 11.
    RESNICK RH, IBER FL, ISHIHARA AM, CHALMERS T, ZIMMERMAN H: A controlled study of the therapeutic portacaval shunt. Gastroenterology 67: 843–857, 1974PubMedGoogle Scholar
  12. 12.
    RUEFF B, DEGOS F, DEGOS JD, MAILHARD JN, PRANDI D, SICOT J, SICOT C, FAUVERT R, BENHAMOU JP: A controlled study of therapeutic portacaval shunt in alcoholic cirrhosis. Lancet 1: 655–659, 1976PubMedCrossRefGoogle Scholar
  13. 13.
    WARREN WD, RESTRAPO JE, RESPASS JC, MULLER WH, JR: The importance of hemodynamic studies in the management of portal hypertension. Ann Surg 158: 387–392, 1963PubMedGoogle Scholar
  14. 14.
    ZIMMON DS, KESSLER RE: Hepatic hemodynamic factors reflect prognosis after portacaval shunt. Gastroenterology 64: 166, 1973Google Scholar
  15. 15.
    ZEPPA R, WARREN WD: The distal splenorenal shunt. Am J Surg 122: 300–303, 1971PubMedCrossRefGoogle Scholar
  16. 16.
    HUTSON DG, PEREVICS R, ZEPPA R, LEVI JU, SCHIFF ER, FINK P: The fate of esophageal varices following selective distal splenorenal shunt. Ann Surg 183: 496–501, 1976PubMedCrossRefGoogle Scholar
  17. 17.
    WEINBERGER HA: Emergency portacaval shunt for esophagogastric hemorrhage. Arch Surg 91: 333–337, 1965CrossRefGoogle Scholar
  18. 18.
    PRESTON FW, TRIPPEL OH: Emergency portacaval shunt; use in patients with alcoholic cirrhosis. Arch Surg 90: 770–781, 1965PubMedCrossRefGoogle Scholar
  19. 19.
    CONN HO: The prognosis and management of bleeding esophageal varices. Ann NY Acad Sci 170: 345–357, 1970CrossRefGoogle Scholar
  20. 20.
    ORLOFF MJ, CHARTERS AC, CHANDLER JG, CONDON JK, GRAMBORT DE, MODAFFERI TR, LEVIN SE, BROWN NB, SVIOKLA SC, KNOX DG: Portacaval shunt as emergency procedure in unselected patients with alcoholic cirrhosis. Surg Gynecol Obstet 141: 59–68, 1975PubMedGoogle Scholar
  21. 21.
    ALEXANDER JF, LISCHNER MW, GALAMBOS JT: Natural history of alcoholic hepatitis. Am J Gastroenterology 56: 515–525, 1971Google Scholar
  22. 22.
    HELMAN RA, TEMKO MH, NYE FW, FALLON HJ: Alcoholic hepatitis. Natural history and evaluation of prednisolone therapy. Ann Int Med 74: 311–321, 1971PubMedGoogle Scholar
  23. 23.
    PORTER HP, SIMON FR, POPE CE III, VOLWILER W, FENSTER LF: Corticosteroid therapy in severe alcoholic hepatitis. N Eng J Med 284: 1350–1355, 1971CrossRefGoogle Scholar
  24. 24.
    CAMPRA J, HAMLIN EM, JR, KIRSHBAUM RJ, OLEVIER M, REDEKER AG, REYNOLDS TB: Prednisone therapy of acute alcoholic hepatitis. Ann Int Med 79: 625–631, 1973PubMedGoogle Scholar
  25. 25.
    BLITZER BC: Adrenocorticosteroid therapy in alcoholic hepatitis. A prospective, double-blind, randomized study. Yale M.D. Thesis, 1973Google Scholar
  26. 26.
    RESNICK RH, cited by CONN HO in L. Schiff, Diseases of the Liver, 4th Ed., Philadelphia, Lippincott, 1975. pp.917Google Scholar
  27. 27.
    MADDREY WC, BORTNOTT JK, WEBER FL, JR, BEDINE MS, HARRINGTON DP, WHITE RI, MEZEY E: Corticosteroid therapy of active alcoholic liver disease. A controlled trial. Gastroenterology 69: 813, 1975Google Scholar
  28. 28.
    ROJKIND M, KERSHENOBICH D: Hepatic fibrosis. In Progress in Liver Diseases. H. Popper and F. Schaffner, (Eds.). New York, Grune and Stratton, 1976. pp. 294–310.Google Scholar
  29. 29.
    NIMNI ED, BAVETTA LH: Collagen defect induced by penicillamine. Science 150: 905–907, 1965PubMedCrossRefGoogle Scholar
  30. 30.
    ROJKIND M, URIBE M, KERSHENOBICH D: Colchicine and the treatment of liver fibrosis. Lancet 1: 38–39, 1973CrossRefGoogle Scholar
  31. 31.
    ISRAEL Y, VIDELA L, BERNSTEIN J: Liver hypermetabolic state after chronic ethanol consumption: Hormonal interrelations and pathogenic implications. Fed Proc 34: 2052–2059, 1975PubMedGoogle Scholar
  32. 32.
    KHANNA JM, KALANT H, YEE Y, CHUNG S, SIEMENS AJ: Effect of chronic ethanol treatment on metabolism of drugs in vitro and in vivo. Biochem Pharmacology 25: 329–335, 1976CrossRefGoogle Scholar
  33. 33.
    CEDERBAUM AI, RUBIN E: Molecular injury to mitochondria produced by ethanol and acetaldehyde. Fed Proc 34: 2045–2051, 1975PubMedGoogle Scholar
  34. 34.
    LEVY LJ, DUGA J, GIRGIS M, GORDON EE: Ketoacidosis associated with alcoholism in nondiabetic subjects. Ann Int Med 78: 213–219, 1973PubMedGoogle Scholar
  35. 35.
    COOPERMAN MT, DAVIDOFF F, SPARK R, PALLOTTA J: Clinical studies of alcoholic ketoacidosis. Diabetes 23: 433–439, 1974PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1977

Authors and Affiliations

  • Kurt J. Isselbacher
    • 1
  • Edward R. Feller
    • 1
  1. 1.Department of Medicine, Harvard Medical School and Gastrointestinal UnitMassachusetts General HospitalBostonUSA

Personalised recommendations